Fournier’s Gangrene and Sodium-Glucose Cotransporter 2 Inhibitor Use: A Report of Two Cases

Necrotizing fasciitis is a serious infection that requires prompt surgical excision and broad spectrum antibiotics. Fournier's gangrene (FG) is a type of necrotizing fasciitis that specifically affects the perineal, scrotal, and genital region. FG is a known adverse outcome of the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This class of drugs is most commonly use to treat diabetes, but recently it's use has expanded to include those with heart failure, regardless of whether they have diabetes. With the increased use of SGLT2 inhibitors, the incidence of FG may increase as well. We present 2 case reports of patients who experienced FG while on SGLT2 inhibitor therapy.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy Practice
Published
2024-11-20
DOI
https://doi.org/10.1177/08971900241302881
Citations
1
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fournier’s Gangrene and Sodium-Glucose Cotransporter 2 Inhibitor Use: A Report of Two Cases

Harry C. Karydes, Zane Elfessi, Sarah Zavala, Elizabeth Portnoy
1 citations
Journal of Pharmacy Practice
Streptococcal Infections and Treatments
0.54
article

Fournier’s Gangrene and Sodium-Glucose Cotransporter 2 Inhibitor Use: A Report of Two Cases

Harry C. Karydes, Zane Elfessi, Sarah Zavala, Elizabeth Portnoy
article en
1 citations

Abstract

Necrotizing fasciitis is a serious infection that requires prompt surgical excision and broad spectrum antibiotics. Fournier's gangrene (FG) is a type of necrotizing fasciitis that specifically affects the perineal, scrotal, and genital region. FG is a known adverse outcome of the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This class of drugs is most commonly use to treat diabetes, but recently it's use has expanded to include those with heart failure, regardless of whether they have diabetes. With the increased use of SGLT2 inhibitors, the incidence of FG may increase as well. We present 2 case reports of patients who experienced FG while on SGLT2 inhibitor therapy.

Journal of Pharmacy PracticeVol. 38(4)
University of Illinois Chicago (US), Jesse Brown VA Medical Center (US)
Good health and well-being
Openalex Percentile: Top 27%
Streptococcal Infections and Treatments
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.